Annual Total Expenses
$17.11 M
-$26.19 M-60.49%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual total expenses is $17.11 million, with the most recent change of -$26.19 million (-60.49%) on December 1, 2023.
- During the last 3 years, ORMP annual total expenses has risen by +$8.64 million (+102.11%).
- ORMP annual total expenses is now -60.49% below its all-time high of $43.30 million, reached on December 31, 2022.
Performance
ORMP Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$3.09 M
-$46.00 K-1.47%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly total expenses is $3.09 million, with the most recent change of -$46.00 thousand (-1.47%) on September 1, 2024.
- Over the past year, ORMP quarterly total expenses has dropped by -$788.00 thousand (-20.32%).
- ORMP quarterly total expenses is now -74.45% below its all-time high of $12.09 million, reached on June 30, 2022.
Performance
ORMP Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ORMP Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.5% | -20.3% |
| 3 y3 years | +102.1% | -74.5% |
| 5 y5 years | -1.3% | +2.1% |
ORMP Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.5% | +29.3% | -74.5% | +6.8% |
| 5 y | 5-year | -60.5% | +102.1% | -74.5% | +6.8% |
| alltime | all time | -60.5% | >+9999.0% | -74.5% | >+9999.0% |
Oramed Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.09 M(-1.5%) |
| Jun 2024 | - | $3.13 M(+5.8%) |
| Mar 2024 | - | $2.96 M(-23.6%) |
| Dec 2023 | $17.11 M(-60.5%) | $3.88 M(+34.0%) |
| Sep 2023 | - | $2.89 M(-35.2%) |
| Jun 2023 | - | $4.46 M(-24.0%) |
| Mar 2023 | - | $5.87 M(-43.6%) |
| Dec 2022 | $43.30 M(+227.3%) | $10.42 M(+17.5%) |
| Sep 2022 | - | $8.87 M(-26.6%) |
| Jun 2022 | - | $12.09 M(+1.5%) |
| Mar 2022 | - | $11.92 M(+36.5%) |
| Dec 2021 | $13.23 M(-50.9%) | - |
| Nov 2021 | - | $8.73 M(+7.9%) |
| Aug 2021 | $26.93 M(+218.1%) | $8.09 M(+19.0%) |
| May 2021 | - | $6.80 M(+22.9%) |
| Feb 2021 | - | $5.53 M(-14.9%) |
| Dec 2020 | $8.46 M(-41.5%) | - |
| Nov 2020 | - | $6.50 M(+75.8%) |
| Aug 2020 | $14.47 M(-16.5%) | $3.70 M(+25.1%) |
| May 2020 | - | $2.96 M(-37.3%) |
| Feb 2020 | - | $4.71 M(+51.8%) |
| Nov 2019 | - | $3.10 M(+2.5%) |
| Aug 2019 | $17.33 M(+8.5%) | $3.03 M(-36.4%) |
| May 2019 | - | $4.76 M(+12.4%) |
| Feb 2019 | - | $4.23 M(-20.3%) |
| Nov 2018 | - | $5.31 M(+41.1%) |
| Aug 2018 | $15.98 M(+20.8%) | $3.77 M(-26.9%) |
| May 2018 | - | $5.15 M(+38.7%) |
| Feb 2018 | - | $3.71 M(+11.1%) |
| Nov 2017 | - | $3.34 M(-3.7%) |
| Aug 2017 | $13.23 M(+24.2%) | $3.47 M(+25.2%) |
| May 2017 | - | $2.77 M(-30.3%) |
| Feb 2017 | - | $3.98 M(+32.2%) |
| Nov 2016 | - | $3.01 M(-22.7%) |
| Aug 2016 | $10.65 M(+44.3%) | $3.89 M(+71.2%) |
| May 2016 | - | $2.27 M(+11.6%) |
| Feb 2016 | - | $2.04 M(-16.8%) |
| Nov 2015 | - | $2.45 M(+12.7%) |
| Aug 2015 | $7.38 M | $2.17 M(+33.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| May 2015 | - | $1.63 M(-2.4%) |
| Feb 2015 | - | $1.67 M(-12.0%) |
| Nov 2014 | - | $1.90 M(+15.3%) |
| Aug 2014 | $5.91 M(+37.2%) | $1.65 M(-13.3%) |
| May 2014 | - | $1.90 M(+60.5%) |
| Feb 2014 | - | $1.19 M(+1.5%) |
| Nov 2013 | - | $1.17 M(+19.5%) |
| Aug 2013 | $4.30 M(+49.2%) | $977.70 K(-26.7%) |
| May 2013 | - | $1.33 M(+5.9%) |
| Feb 2013 | - | $1.26 M(+72.2%) |
| Nov 2012 | - | $731.80 K(-21.9%) |
| Aug 2012 | $2.88 M(+18.4%) | $937.30 K(+73.4%) |
| May 2012 | - | $540.40 K(-42.5%) |
| Feb 2012 | - | $940.40 K(+101.8%) |
| Nov 2011 | - | $465.90 K(-21.7%) |
| Aug 2011 | $2.44 M(-18.1%) | $595.00 K(+0.6%) |
| May 2011 | - | $591.50 K(-8.6%) |
| Feb 2011 | - | $647.20 K(+7.6%) |
| Nov 2010 | - | $601.60 K(-48.0%) |
| Aug 2010 | $2.97 M(+6.8%) | $1.16 M(+43.6%) |
| May 2010 | - | $806.00 K(+105.7%) |
| Feb 2010 | - | $391.90 K(-36.5%) |
| Nov 2009 | - | $617.50 K(+52.9%) |
| Aug 2009 | $2.78 M(+3.9%) | $403.80 K(-24.1%) |
| May 2009 | - | $531.80 K(-17.7%) |
| Feb 2009 | - | $646.50 K(-46.2%) |
| Nov 2008 | - | $1.20 M(+8.4%) |
| Aug 2008 | $2.68 M(-14.4%) | $1.11 M(+31.2%) |
| May 2008 | - | $845.00 K(+132.1%) |
| Feb 2008 | - | $364.10 K(+0.9%) |
| Nov 2007 | - | $361.00 K(-85.5%) |
| Aug 2007 | $3.13 M(+658.5%) | $2.49 M(+746.2%) |
| May 2007 | - | $294.60 K(+9.8%) |
| Feb 2007 | - | $268.30 K(+252.6%) |
| Nov 2006 | - | $76.10 K(-72.7%) |
| Aug 2006 | $412.90 K(+821.7%) | $278.70 K(+119.6%) |
| May 2006 | - | $126.90 K(+7831.3%) |
| Feb 2006 | - | $1600.00(-68.0%) |
| Nov 2005 | - | $5000.00 |
| Aug 2005 | $44.80 K | - |
FAQ
- What is Oramed Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual total expenses year-on-year change?
- What is Oramed Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly total expenses year-on-year change?
What is Oramed Pharmaceuticals annual total expenses?
The current annual total expenses of ORMP is $17.11 M
What is the all time high annual total expenses for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual total expenses is $43.30 M
What is Oramed Pharmaceuticals annual total expenses year-on-year change?
Over the past year, ORMP annual total expenses has changed by -$26.19 M (-60.49%)
What is Oramed Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ORMP is $3.09 M
What is the all time high quarterly total expenses for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly total expenses is $12.09 M
What is Oramed Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, ORMP quarterly total expenses has changed by -$788.00 K (-20.32%)